http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105288621-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105288621-B
titleOfInvention Infrared excitation for anticancer can generate the optothermal material and preparation method of UVC- visible emissions
abstract The present invention's provides a kind of infrared excitation for anticancer and can generate the optothermal material and preparation method of UVC- visible emissions.A kind of rare-earth nano-crystal with photoresponse UVC and light thermal property prepared by cladding process layer by layer by high temperature pyrolytic cracking (HTP), since this material has photoresponse ultraviolet light, VISIBLE LIGHT EMISSION, photo-thermal simultaneously under the irradiation of 808 nanometer lasers, to the synergistic antitumor performance with light guiding, diagnosis and treatment integration is realized.The technical characteristic of material of the present invention is:(1) the nanocrystalline narrow particle size distribution generated has compared with small particle (about 35 nanometers), can be used for killing cancer cell.(2) nanocrystalline to launch the distinguishable violet visible of human eye under the irradiation of 808 nanometer lasers, while short wave ultraviolet can be generated.(3) this material itself has photothermy since Nd has absorption peak in 808 nanometers.
priorityDate 2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 17.